Evidence map›Paper›PMID 36895936›Full record

ArticleTranslational lung cancer research2023

Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study.

Fernando Rodríguez-Cano, Virginia Calvo, Yago Garitaonaindía, José Luis Campo-Cañaveral de la Cruz, Mariola Blanco, María Torrente, Mariano Provencio

Abstract read
In one paragraph

Article in Translational lung cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Fernando Rodríguez-CanoMedical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Virginia CalvoMedical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Yago GaritaonaindíaMedical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
José Luis Campo-Cañaveral de la CruzThoracic Surgery Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Mariola BlancoMedical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
María TorrenteMedical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Mariano ProvencioMedical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Many patients with non-metastatic non-small cell lung cancer (NSCLC) are cured by surgery but part of them develop recurrence. Strategies are needed to identify these relapses. Currently, there is no consensus on the follow-up schedule after curative resection for patients with NSCLC. The objective of this study is to analyze the diagnostic capacity of the tests performed during follow-up after surgery. Methods: We retrospectively reviewed 392 patients with stage I-IIIA NSCLC who underwent surgery. Data were collected from patients diagnosed between January 1st, 2010 and December 31st, 2020. Demographic and clinical data were analyzed, as well as the tests performed during their follow-up. We identified as relevant in the diagnosis of relapses those tests that prompted further investigation and change of treatment. Results: The number of tests matches those included in clinical practice guidelines. A total of 2,049 clinical follow-up consultations were performed, of which 2,004 were scheduled (0.59% informative). A total of 1,796 blood tests were performed, of which 1,756 were scheduled (0.17% informative). A total of 1,940 chest computer tomography (CT) scans were performed, of which 1,905 were scheduled and 128 were informative (6.7%). A total of 144 positron emission tomography (PET)-CT scans were performed, 132 of which were scheduled, of which 64 (48%) were informative. In all cases, the tests performed by unscheduled request exceeded the informative result of the scheduled ones several fold. Conclusions: Most of the scheduled follow-up consultations were not relevant for the patients' management, and only body CT scan exceeded the threshold of 5% profitability, without reaching 10% even in stage IIIA. The profitability of the tests increased when performed in unscheduled visits. New follow-up strategies based on scientific evidence must be defined and follow-up schemes should be tailored focused on agile attention of the unscheduled demand.

Indexed as

computer tomography scan (CT scan)cost-effectivenessfollow-upNon-small cell lung cancer (NSCLC)

Identifiers

PMID36895936
PMCPMC9989820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.